Literature DB >> 30409740

Sex-related differences in cardiomyopathies.

Francesco Pelliccia1, Giuseppe Limongelli2, Camillo Autore3, Juan Ramón Gimeno-Blanes4, Cristina Basso5, Perry Elliott6.   

Abstract

Cardiomyopathies (CMPs) are a heterogeneous group of heart muscle diseases with several different phenotypes defined as myocardial disorders in which the heart muscle is structurally and functionally abnormal in the absence of coronary artery disease, hypertension, valvular heart disease and congenital heart disease sufficient to explain the observed myocardial abnormality. CMPs can be classified into one of the following, i.e. hypertrophic CMP (HCM), dilated CMP (DCM), arrhythmogenic right ventricular CMP (ARVC), restrictive CMP (RCM), and unclassified CMPs. Although an increasing number of CMPs are now recognized to have a genetic basis, single mutations are associated with phenotypic variability and may cause not only a specific CMP, but also several different CMPs. Recently, it has become evident that, along with environmental interactions, age and sex may affect the penetrance of disease genes thus determining the phenotypic expression of CMPs. Noteworthy, an increasing body of data indicates that sex plays an important role in various forms of CMPs. The mode of inheritance may affect the sex-related occurrence of CMPs. Also, sex is a relevant determinant of the clinical manifestation of CMPs, and sex-related characteristics can be found in all forms. Sex-specific aspects of clinical disease expression as well as potential modes of inheritance should be therefore taken into proper consideration in order to improve the diagnostic work-up and treatment strategy of CMPs in both sexes.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; Familial; Hormones; Sex

Mesh:

Year:  2018        PMID: 30409740     DOI: 10.1016/j.ijcard.2018.10.091

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Genetic Basis of Dilated Cardiomyopathy in Dogs and Its Potential as a Bidirectional Model.

Authors:  Karen R Gaar-Humphreys; Talitha C F Spanjersberg; Giorgia Santarelli; Guy C M Grinwis; Viktor Szatmári; Bernard A J Roelen; Aryan Vink; J Peter van Tintelen; Folkert W Asselbergs; Hille Fieten; Magdalena Harakalova; Frank G van Steenbeek
Journal:  Animals (Basel)       Date:  2022-06-29       Impact factor: 3.231

2.  Hypertrophic cardiomyopathy masked by pericarditis.

Authors:  Larry Nichols; Himara Koelmeyer
Journal:  Autops Case Rep       Date:  2019-09-27

3.  Left Bundle Pacing for Left Bundle Branch Block and Intermittent Third-Degree Atrioventricular Block in a MYH7 Mutation-Related Hypertrophic Cardiomyopathy With Restrictive Phenotype in a Child.

Authors:  Luyan Zhang; Xueying Cheng; Jinlong Chen; Ming Zhou; Tianwei Qian; Zhongman Zhang; Jie Yin; Han Zhang; Genyin Dai; Yuming Qin; Shiwei Yang
Journal:  Front Pediatr       Date:  2020-06-16       Impact factor: 3.418

Review 4.  Septal Ablation Versus Surgical Myomectomy for Hypertrophic Obstructive Cardiomyopathy.

Authors:  F Pelliccia; H Seggewiss; F Cecchi; P Calabrò; G Limongelli; O Alfieri; P Ferrazzi; M H Yacoub; I Olivotto
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 2.931

5.  Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy.

Authors:  Man Xu; Ying-Ying Guo; Dan Li; Xian-Feng Cen; Hong-Liang Qiu; Yu-Lan Ma; Si-Hui Huang; Qi-Zhu Tang
Journal:  Front Cardiovasc Med       Date:  2022-04-01

Review 6.  Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy.

Authors:  Angita Jain; Nadine Norton; Katelyn A Bruno; Leslie T Cooper; Paldeep S Atwal; DeLisa Fairweather
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.